EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Usefulness of Sofosbuvir and Daclatasvir combination in the treatment of HCV infection in childhood cancer patients: experience from a tertiary care hospital

Uzma Imam, Arit Parkash, Nandlal Daryani, Fahad Mumtaz

Journal of the Pakistan Medical Association · 2023

DOI: 10.47391/jpma.8433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2023. Verfasst von Uzma Imam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Oncology, National Institute of Child Health, Karachi, Pakistan. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Neoplasms, Hepatitis C. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the usefulness of Sofosbuvir-Daclatasvir combination in the treatment of hepatitis c virus infection in paediatric cancer.

Method

The retrospective study was conducted at the Oncology Department of the National Institute of Child Health, Karachi, and comprised medical charts of patients who received sofosbuvir and daclatasvir from January 2018 to January 2022. Efficacy was documented by clearance of hepatitis C virus ribonucleic acid as rapid viral response, early viral response and sustained viral response at weeks 4, 12 and 24, respectively. Drug efficacy was determined by monitoring and recording adverse effects. Chemotherapy protocol for the treatment of patients concomitantly receiving direct acting antivirals was modified while looking at drug-drug interactions. The total duration of direct acting antiviral therapy was 12 weeks. Data was analysed using SPSS 24.

Results

Of the 804 patients with different malignancies, 132(16.4%) were found positive for hepatitis C virus. Of them, 28(21.21%) patients were started on direct acting antivirals; 17(60.71%) boys and 11(39.28%) girls. The overall mean age was 9.93±6.12 years. The diagnosis was pre-B acute lymphoblastic leukaemia in 18(64.28%) cases, 16(57.14%) were on maintenance chemotherapy, and 18(64.28%) had genotype 1. Pre- and post-treatment mean alanine transaminase levels were 328.00±324.00IU and 36.00±29.00IU, respectively (p=0.003). Pre- and post-treatment mean serum bilirubin levels were 3.13±3.95mg/dl and 0.61±0.21mg/dl (p=0.022). Rapid viral response was achieved in 26(92.85%) children, while early viral response and sustained viral response were achieved in all 28(100%) patients. Minor side effects were noted in 4(14.28%) patients and chemotherapy was continued in all 28(100%) cases as per the designed protocol.

Conclusion

The sofosbuvir-daclatasvir combination was found to be effective in hepatitis C virus treatment in paediatric cancer patients. Key Words: Childhood cancer, HCV infection, Direct acting antiviral agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicNeoplasmsHepatitis CChildMaleFemaleHumansChild, PreschoolAdolescentSofosbuvirAntiviral AgentsRetrospective StudiesTertiary Care CentersTreatment OutcomeDrug Therapy, CombinationPyrrolidinesHepacivirusGenotypeRibavirinCarbamatesImidazolesValine

Stichwörter der Autor:innen

Childhood cancer, HCV infection, Direct acting antiviral agents.

Substanzen

SofosbuvirAntiviral AgentsPyrrolidinesRibavirindaclatasvirCarbamatesImidazolesValine

Autor:innen und Institutionen

  • Department of Paediatric Oncology, National Institute of Child Health, Karachi, Pakistan.
  • Department of Paediatric Gastroenterology, National Institute of Child Health, Karachi, Pakistan.

Zitieren

APA

Imam, U., Parkash, A., Daryani, N., & Mumtaz, F. (2023). Usefulness of Sofosbuvir and Daclatasvir combination in the treatment of HCV infection in childhood cancer patients: experience from a tertiary care hospital. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.8433

Vancouver

Imam U, Parkash A, Daryani N, Mumtaz F. Usefulness of Sofosbuvir and Daclatasvir combination in the treatment of HCV infection in childhood cancer patients: experience from a tertiary care hospital. Journal of the Pakistan Medical Association. 2023. doi:10.47391/jpma.8433

BibTeX
@article{Imam2023,
  author = {Imam, Uzma and Parkash, Arit and Daryani, Nandlal and Mumtaz, Fahad},
  title = {Usefulness of Sofosbuvir and Daclatasvir combination in the treatment of HCV infection in childhood cancer patients: experience from a tertiary care hospital},
  journal = {Journal of the Pakistan Medical Association},
  year = {2023},
  doi = {10.47391/jpma.8433}
}
Kostenlos starten →